![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 26, 2018 1:53:39 PM
A fascinating augmented report on Bayer reveals that Dr. Scholl's sales had declined for the period. In my view, with Bayer being one of the best managed corporations in the world, Dr. Scholl's is somewhat motivated to grow sales and profits and ActiPatch is substantial way to do it.
http://www.annualreport2016.bayer.com/management-report-annexes/report-on-economic-position/business-development-by-segment/consumer-health.html
Scroll through the report to Dr. Scholl's and I will wager they are looking, not only at the foot, their area of accomplishment for 100 years, but I would be going up the leg, ankle and knee, which ActiPatch is already cleared for and beyond . . . .
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM